Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).

Cancer epidemiology - 1 Dec 2014

Serrano Beatriz, Alemany Laia, Ruiz Patricia Alonso de, Tous Sara, Lima Marcus Aurelho, Bruni Laia, Jain Asha, Clifford Gary M, Qiao You Lin, Weiss Thomas, Bosch F Xavier, de Sanjosé Silvia

Abstract excerpt

BACKGROUND: We estimated the potential impact of an investigational 9-valent human papillomavirus (HPV) vaccine (HPVs 6/11/16/18/31/33/45/52/58) in HPV-related cervical disease in Brazil, Mexico, India and China, to help to formulate recommendations on cervical cancer prevention and control. METHODS: Estimations for invasive cervical cancer (ICC) were based on an international study including 1356 HPV-positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brazil
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Mexico

Share to Papillomaviridae

Share to Papillomavirus Vaccines

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 25305098
DOI: 10.1016/j.canep.2014.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).PMID 25305098Read ↗

The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.Semantic proximity Read ↗

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in KoreaSemantic proximity Read ↗

HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.Semantic proximity Read ↗

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.Semantic proximity Read ↗

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.Semantic proximity Read ↗

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.Semantic proximity Read ↗

Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.Semantic proximity Read ↗

Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria, and Pakistan: a comparative modelling studySemantic proximity Read ↗

Impact of Prophylactic HPV Vaccination on the Prevention of HPV-Driven Oral Cancers in India: Current Progress and Future PerspectivesSemantic proximity Read ↗

HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China.Semantic proximity Read ↗

Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.Semantic proximity Read ↗

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.